One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Computational Re-Entry Vulnerability Index Mapping to Guide Ablation in Patients With Postmyocardial Infarction Ventricular Tachycardia
Pouya Jelvehgaran, P HD, a,b, * Ryan O’Hara, BSC ,c, * Adityo Prakosa, P HD, c Jonathan Chrispin, MD,d Gerard J.J. Boink, MD, PHD, a,e Natalia Trayanova, PHD, c,y Ruben Coronel, MD, PHD, a,f,y Thom Oostendorp, PH D
doi : 10.1016/j.jacep.2022.10.002
Volume 9, Issue 3, March 2023, Pages 301-310
Ventricular tachycardias (VTs) in patients with myocardial infarction (MI) are often treated with catheter ablation.
A Virtual Step Toward Precision Scar-Related Ventricular Tachycardia Ablation∗
Mark J. Davies, BSC (HONS), MB BC HIR, PH D, MRCP, a,b Jason S. Bradfield, MD
doi : 10.1016/j.jacep.2023.02.005
Volume 9, Issue 3, March 2023, Pages 311-313
Different Phases of Disease in Lymphocytic Myocarditis: Clinical and Electrophysiological Characteristics
Michela Casella, MD, P HD, a,b, * Alessio Gasperetti, MD, c, * Paolo Compagnucci, MD, a,d Maria Lucia Narducci, MD, PH D, e Gemma Pelargonio, MD, PHD, e,f Valentina Catto, PH D, c Corrado Carbucicchio, MD,c Gianluigi Bencardino, MD, PH D, e Edoardo Conte, MD,g Nicolò Schicchi, MD, h Daniele Andreini, MD, P HD, g,i Gianluca Pontone, MD, PHD, g Andrea Giovagnoni, MD, b,h Stefania Rizzo, MD,j Frediano Inzani, MD, k Cristina Basso, MD, P HD, j Andrea Natale, MD,l Claudio Tondo, MD, PHD, f,m Antonio Dello Russo, MD, PH D, a,d Filippo Crea, MD
doi : 10.1016/j.jacep.2022.10.004
Volume 9, Issue 3, March 2023, Pages 314-326
Phase of Disease Matters: Inflammation, Scar, and Ventricular Arrhythmias in Lymphocytic Myocarditis∗
Leah A. John, MD, MBA, Sanjay Divakaran, MD, Usha Tedrow, MD, MS
doi : 10.1016/j.jacep.2022.11.013
Volume 9, Issue 3, March 2023, Pages 327-329
Radiofrequency Ablation of the Diseased Human Left Ventricle: Biophysical and Electrogram-Based Analysis
Alexander P. Bates, MB BC HIR,a,b John Paisey, MD, a Arthur Yue, MA, MD, a Phil Banks, BSC ,a Paul R. Roberts, MD, a Waqas Ullah, PHD
doi : 10.1016/j.jacep.2022.10.001
Volume 9, Issue 3, March 2023, Pages 330-340
Predictors of effective ablation lesion delivery in the human left ventricle are not established, particularly in scar. Impedance drop and electrogram (EGM) attenuation are potential surrogates to assess this.
Precision Medicine and Ablation of Ventricular Arrhythmias: The Difficulty of Estimating Lesion Size and Durability∗
William H. Sauer, MD, a Omar Kreidieh, MD
doi : 10.1016/j.jacep.2022.10.037
Volume 9, Issue 3, March 2023, Pages 341-344
Importance of Systematic Diagnostic Testing in Idiopathic Ventricular Fibrillation: Results From the Dutch iVF Registry
Sanne A. Groeneveld, MD, a Lisa M. Verheul, MD, a Martijn H. van der Ree, MD,b Bart A. Mulder, MD, PH D, c Marcoen F. Scholten, MD, PHD, d Marco Alings, MD, PH D, e Pepijn van der Voort, MD, f Marianne Bootsma, MD, P HD, g Reinder Evertz, MD, h Jippe C. Balt, MD, PH D, i Sing-Chien Yap, MD, P HD, j Pieter.A.F.M. Doevendans, MD, PHD, a,k Pieter G. Postema, MD, PH D, b,l Arthur A.M. Wilde, MD, PHD, b,l Paul G.A. Volders, MD, P HD, l,m Rutger J. Hassink, MD, PH D
doi : 10.1016/j.jacep.2022.10.003
Volume 9, Issue 3, March 2023, Pages 345-355
Seeking Certainty About the Uncertain∗
Christian Steinberg, MD,a Andrew D. Krahn, MD
doi : 10.1016/j.jacep.2022.11.028
Volume 9, Issue 3, March 2023, Pages 356-358
Heart Rate Variability Analysis May Identify Individuals With Williams-Beuren Syndrome at Risk of Sudden Death
Mark D. Levin, MD,a, * Brianna M. Cathey, BS, a,b, * Kevin Smith, RN,c Sharon Osgood, RN,d Neelam Raja, RN, CNRP, a Yi-Ping Fu, P HD, e Beth A. Kozel, MD, PH D
doi : 10.1016/j.jacep.2022.10.010
Volume 9, Issue 3, March 2023, Pages 359-370
Williams-Beuren syndrome (WBS) (Online Mendelian Inheritance in Man #194050) is a rare genetic multisystem disorder resulting from a chromosomal microdeletion at 7q11.23. The condition is characterized by distinct facies, intellectual disability, and supravalvar aortic stenosis. Those with WBS have an increased risk of sudden death, but mechanisms underlying this phenotype are incompletely understood.
Acute Modulation of Left Ventricular Control by Selective Intracardiac Sympathetic Denervation
Ann-Kathrin Kahle, MD,a,b,c,d Niklas Klatt, MD, c,e Christiane Jungen, MD,c,f,g Aaron Dietenberger,f Pawel Kuklik, PHD, h Paula Münkler, MD,c,f Stephan Willems, MD,c,h Viacheslav Nikolaev, PH D, c,i Dainius H. Pauza, PHD, j Katharina Scherschel, P HD, a,b,c Christian Meyer, MD, MA
doi : 10.1016/j.jacep.2022.10.013
Volume 9, Issue 3, March 2023, Pages 371-384
The sympathetic nervous system plays an integral role in cardiac physiology. Nerve fibers innervating the left ventricle are amenable to transvenous catheter stimulation along the coronary sinus (CS).
Conduction System Pacing Versus Conventional Cardiac Resynchronization Therapy in Congenital Heart Disease
Jeremy P. Moore, MD, MS, a,b,c Natasja M.S. de Groot, MD, P HD, d Matthew O’Connor, MD, e Daniel Cortez, MD, PHD, f,g Jonathan Su, MD, c Austin Burrows, BA, h Kevin M. Shannon, MD,a,b,c Edward T. O’Leary, MD,i Maully Shah, MBBS, j Paul Khairy, MD, PHD, k Joseph Atallah, MD, CM, SM, l Tom Wong, MD,e Michael S. Lloyd, MD, m Yannick J.H.J. Taverne, MD, PH D, n Anne M. Dubin, MD,o Jens C. Nielsen, MD, p,q Reinder Evertz, MD, MSC ,r Richard J. Czosek, MD,s,t Malini Madhavan, MBBS,u Philip M. Chang, MD, v Alper Aydin, MD, w Óscar Cano, MD
doi : 10.1016/j.jacep.2022.10.012
Volume 9, Issue 3, March 2023, Pages 385-393
Dyssynchrony-associated left ventricular systolic dysfunction is a major contributor to heart failure in congenital heart disease (CHD). Although conventional cardiac resynchronization therapy (CRT) has shown benefit, the comparative efficacy of cardiac conduction system pacing (CSP) is unknown.
Subcutaneous and Transvenous Defibrillators in Arrhythmogenic Right Ventricular Cardiomyopathy: A Comparison of Clinical and Quality-of-Life Outcomes
Weijia Wang, MD, MPH,a Alessio Gasperetti, MD,a Samuel F. Sears, PHD, b Crystal Tichnell, MGC, RN,a Brittney Murray, MS,a Harikrishna Tandri, MD,a Cynthia A. James, SC M, PH D, a Hugh Calkins, MD
doi : 10.1016/j.jacep.2022.09.020
Volume 9, Issue 3, March 2023, Pages 394-402
There is limited evidence guiding the selection between subcutaneous and transvenous implantable cardioverter-defibrillators (ICDs) in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) at risk for sudden death.
Heart Failure Burden by Autopsy, Guideline-Directed Medical Therapy, and ICD Utilization Among Sudden Deaths
Satvik Ramakrishna, MD, a James W. Salazar, MD, MAS, b Jeffrey E. Olgin, MD, b Ellen Moffatt, MD, c Zian H. Tseng, MD, MAS b
doi : 10.1016/j.jacep.2022.10.018
Volume 9, Issue 3, March 2023, Pages 403-413
Sudden Cardiac Death: In Search of a New Standard
Matthew C. Hyman, MD, P HD, Rajat Deo, MD, MTR
doi : 10.1016/j.jacep.2022.12.005
Volume 9, Issue 3, March 2023, Pages 414-415
Atrial Fibrillation/Atrial Flutter Tachy-Cardiomyopathy: New Observations on Cardiac MRI and Treatment
Savahanna Wagner, DO, MPHy Sunit-Preet Chaudhry, MDy Saad Ali, DO Huseyin E. Arman, DO Benzy J. Padanilam, MD Jasen L. Gilge, MD *Eric N. Prystowsky, MD
doi : 10.1016/j.jacep.2022.09.024
Volume 9, Issue 3, March 2023, Pages 416-418
Loss of Capture During Long Term Follow-Up After Left-Bundle-Branch-Pacing
Shunmuga Sundaram Ponnusamy, MD, DM, CEPS Vithiya Ganesan, MD Pugazhendhi Vijayaraman, MD
doi : 10.1016/j.jacep.2022.10.006
Volume 9, Issue 3, March 2023, Pages 418-420
Prognostic Value of Heart Rate Preceding Ventricular Tachyarrhythmias Among ICD Patients With Left Ventricular Dysfunction
Javier Jiménez-Candil, MD, PhD Jesús Hernández, MD Armando Oterino, MD Juan Carlos Castro, MD Olga Durán, MD José L. Morinigo, MD, PhD Manuel Sánchez GarcÃa, MD Pedro L. Sánchez, MD, PhD
doi : 10.1016/j.jacep.2022.10.007
Volume 9, Issue 3, March 2023, Pages 420-422
Atrial Fibrillation Ablation and Takotsubo Syndrome: Prevention/Prognostication/Management?
*John E. Madias, MD
doi : 10.1016/j.jacep.2023.01.036
Volume 9, Issue 3, March 2023, Pages 422-423
Reply: Atrial Fibrillation Ablation and Takotsubo Syndrome: Prevention/Prognostication/Management?
Sanghamitra Mohanty, MD, MS *Andrea Natale, MD
doi : 10.1016/j.jacep.2023.02.008
Volume 9, Issue 3, March 2023, Pages 423-424
Junctional Tachycardia: A Critical Reassessment
Patrick Tchou, MD, David Nemer, MD, Walid Saliba, MD, Niraj Varma, MD, Peter Aziz, MD, Akash Patel, MD, Hiroshi Nakagawa, MD, P HD, Mohamed Kanj, MD, Ayman Hussein, MD, Mandeep Bhargava, MD, Oussama Wazni, MD
doi : 10.1016/j.jacep.2022.10.040
Volume 9, Issue 3, March 2023, Pages 425-441
Junctional tachycardia (JT) is typically considered to have an automatic mechanism originating from the distal atrioventricular node. When there is 1:1 retrograde conduction via the fast pathway, JT would resemble the typical form of atrioventricular nodal re-entrant tachycardia (AVNRT).
Traumatic Syncope Caused by Prolonged Ventricular Arrhythmias With a Defibrillator Programmed to 2019 Consensus Recommendations
Adam Oesterle, MD, a L. Bing Liem, DO, a Sanket S. Dhruva, MD, a Gareth Friday, BS C,b Merritt H. Raitt, MD, c Cara N. Pellegrini, MD a
doi : 10.1016/j.jacep.2022.11.012
Volume 9, Issue 3, March 2023, Pages 442-443
The Atrioventricular Bundle: A Sesquicentennial Tribute to Professor Sunao Tawara
Shumpei Mori, MD, PHD, Peter Hanna, MD, PHD, Raj V. Bhatt, Kalyanam Shivkumar, MD, P HD
doi : 10.1016/j.jacep.2022.11.011
Volume 9, Issue 3, March 2023, Pages 444-447
Atrial Tachycardia With Concomitant Prolonged HV Interval With an SCN5AÂ Missense Variant (p.R367H)
Zhaomin Li, MD, a Qing Wang, MD, a Xingxing Sun, MD,b Yike Zhang, MD,a Chang Cui, MD, a Hongwu Chen, MD, a Minglong Chen, MD
doi : 10.1016/j.jacep.2022.11.018
Volume 9, Issue 3, March 2023, Pages 448-452
JACC: Clinical Electrophysiology 2022Â Young Author Award Winner
Kalyanam Shivkumar, MD, PH D
doi : 10.1016/j.jacep.2023.02.001
Volume 9, Issue 3, March 2023, Pages 453-454
